ADMA Biologics: Class Action Lawsuit Application Deadline Set for August
A securities class action lawsuit involving ADMA Biologics, Inc. shareholders has set an application deadline of August 10, 2026.
ADMA Biologics, Inc. (NasdaqGM: ADMA) has announced that the deadline for applications in a securities class action lawsuit concerning the company's shareholders is August 10, 2026.
The law firm Kahn Swick & Foti, LLC (KSF), along with partner Charles C. Foti, Jr., is notifying investors of the lawsuit. The suit alleges potential violations of securities laws, claiming the company may have issued misleading statements that affected its stock price.
Investors who purchased ADMA Biologics shares within a specified period and suffered losses are advised to contact KSF before the deadline to potentially be included in the class action. The firm is leading the legal effort on behalf of affected shareholders.
Further details regarding the lawsuit and the process for inclusion are available through the law firm. Opportunities for individual investors to join the action may be limited after the established deadline.